Caspase 3 activation during herpes simplex virus 1 infection

Virus Research

Volumn 120, Issue 1-2, 2006, Pages 163-175

  Kraft, Rachel M ^a   Nguyen, Marie L ^a   Yang, Xiao He ^b   Thor, Ann D ^b   Blaho, John A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; HEp 2 and MCF 7 tumor cells; Herpes simplex virus 1

Indexed keywords

CASPASE 3;

APOPTOSIS; ARTICLE; CELL KILLING; CELL STRUCTURE; CONTROLLED STUDY; DNA VIRUS; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HOST CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CASPASES; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; ENZYME PRECURSORS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; VERO CELLS; VIRUS ASSEMBLY;

HUMAN HERPESVIRUS 1; MIRIDAE;

EID: 33745368800     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.03.003     Document Type: Article

References (60)

1. Aubert M., and Blaho J.A. The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J. Virol. 73 4 (1999) 2803-2813
2. Aubert M., and Blaho J.A. Modulation of apoptosis during herpes simplex virus infection in human cells. Microbes Infect. 3 10 (2001) 859-866
3. Aubert M., and Blaho J.A. Viral oncoapoptosis of human tumor cells. Gene Ther. 10 17 (2003) 1437-1445
4. Aubert M., O'Toole J., and Blaho J.A. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J. Virol. 73 12 (1999) 10359-10370
5. Aubert M., Rice S.A., and Blaho J.A. Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells. J. Virol. 75 2 (2001) 1013-1030
6. Baines J.D., Cunningham C., Nalwanga D., and Davison A. The U(L)15 gene of herpes simplex virus type 1 contains within its second exon a novel open reading frame that is translated in frame with the U(L)15 gene product. J. Virol. 71 4 (1997) 2666-2673
7. Baines J.D., Poon A.P., Rovnak J., and Roizman B. The herpes simplex virus 1 UL15 gene encodes two proteins and is required for cleavage of genomic viral DNA. J. Virol. 68 12 (1994) 8118-8124
8. Blaho J.A. Virus infection and apoptosis (issue II) an introduction: cheating death or death as a fact of life?. Int. Rev. Immunol. 23 1-2 (2004) 1-6
9. Chen T.R. Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet. Cell Genet. 48 1 (1988) 19-24
10. DeLuca N.A., McCarthy A.M., and Schaffer P.A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56 2 (1985) 558-570
11. DeLuca N.A., and Schaffer P.A. Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol. Cell Biol. 5 8 (1985) 1997-2008
12. DeLuca N.A., and Schaffer P.A. Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15 11 (1987) 4491-4511
13. DeLuca N.A., and Schaffer P.A. Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J. Virol. 62 3 (1988) 732-743
14. Galvan V., Brandimarti R., Munger J., and Roizman B. Bcl-2 blocks a caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 infection in HEp-2 cells. J. Virol. 74 4 (2000) 1931-1938
15. Galvan V., Brandimarti R., and Roizman B. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death. J. Virol. 73 4 (1999) 3219-3226
16. Galvan V., and Roizman B. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 95 7 (1998) 3931-3936
17. Goodkin M.L., Morton E.R., and Blaho J.A. Herpes simplex virus infection and apoptosis. Int. Rev. Immunol. 23 1-2 (2004) 141-172
18. Goodkin M.L., Ting A.T., and Blaho J.A. NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J. Virol. 77 13 (2003) 7261-7280
19. Grigoriev M.Y., Pozharissky K.M., Hanson K.P., Imyanitov E.N., and Zhivotovsky B. Expression of caspase-3 and -7 does not correlate with the extent of apoptosis in primary breast carcinomas. Cell Cycle 1 5 (2002) 337-342
20. Hardwicke M.A., Vaughan P.J., Sekulovich R.E., O'Conner R., and Sandri-Goldin R.M. The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule. J. Virol. 63 11 (1989) 4590-4602
21. Janicke R.U., Sprengart M.L., Wati M.R., and Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273 16 (1998) 9357-9360
22. Jerome K.R., Fox R., Chen Z., Sears A.E., Lee H., and Corey L. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 73 11 (1999) 8950-8957
23. Kerr J.F., Winterford C.M., and Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer 73 8 (1994) 2013-2026
24. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26 4 (1972) 239-257
25. Koyama A.H., and Adachi A. Induction of apoptosis by herpes simplex virus type 1. J. Gen. Virol. 78 Pt 11 (1997) 2909-2912
26. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., and Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384 6607 (1996) 368-372
27. Langelier Y., Bergeron S., Chabaud S., Lippens J., Guilbault C., Sasseville A.M., Denis S., Mosser D.D., and Massie B. The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J. Gen. Virol. 83 Pt 11 (2002) 2779-2789
28. Leopardi R., and Roizman B. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc. Natl. Acad. Sci. U.S.A. 93 18 (1996) 9583-9587
29. Leopardi R., Van Sant C., and Roizman B. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. U.S.A. 94 15 (1997) 7891-7896
30. McCarthy A.M., McMahan L., and Schaffer P.A. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 63 1 (1989) 18-27
31. Moore A.E., Sabachewsky L., and Toolan H.W. Culture characteristics of four permanent lines of human cancer cells. Cancer Res. 15 9 (1955) 598-602
32. Neamati N., Fernandez A., Wright S., Kiefer J., and McConkey D.J. Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J. Immunol. 154 8 (1995) 3788-3795
33. Nelson-Rees W.A., Zhdanov V.M., Hawthorne P.K., and Flandermeyer R.R. HeLa-like marker chromosomes and type-A variant glucose-6-phosphate dehydrogenase isoenzyme in human cell cultures producing Mason-Pfizer monkey virus-like particles. J. Natl. Cancer. Inst. 53 3 (1974) 751-757
34. Nguyen M.L., Kraft R.M., and Blaho J.A. African green monkey kidney Vero cells require de novo protein synthesis for efficient herpes simplex virus 1-dependent apoptosis. Virology 336 2 (2005) 274-290
35. Ogura H., Yoshinouchi M., Kudo T., Imura M., Fujiwara T., and Yabe Y. Human papillomavirus type 18 DNA in so-called HEP-2, KB and FL cells-further evidence that these cells are HeLa cell derivatives. Cell Mol. Biol. (Noisy-le-grand) 39 5 (1993) 463-467
36. Perkins D., Pereira E.F., and Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J. Virol. 77 2 (2003) 1292-1305
37. Perng G.C., Jones C., Ciacci-Zanella J., Stone M., Henderson G., Yukht A., Slanina S.M., Hofman F.M., Ghiasi H., Nesburn A.B., and Wechsler S.L. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287 5457 (2000) 1500-1503
38. Petrovskis E.A., Meyer A.L., and Post L.E. Reduced yield of infectious pseudorabies virus and herpes simplex virus from cell lines producing viral glycoprotein gp50. J. Virol. 62 6 (1988) 2196-2199
39. Pomeranz L.E., and Blaho J.A. Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J. Virol. 73 8 (1999) 6769-6781
40. Poon A.P., and Roizman B. Characterization of a temperature-sensitive mutant of the UL15 open reading frame of herpes simplex virus 1. J. Virol. 67 8 (1993) 4497-4503
41. Sacks W.R., Greene C.C., Aschman D.P., and Schaffer P.A. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 55 3 (1985) 796-805
42. Salvesen G.S., and Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 91 4 (1997) 443-446
43. Sanfilippo C.M., and Blaho J.A. The facts of death. Int. Rev. Immunol. 22 5-6 (2003) 327-340
44. Sanfilippo C.M., Chirimuuta F.N., and Blaho J.A. Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells. J. Virol. 78 1 (2004) 224-239
45. Sekulovich R.E., Leary K., and Sandri-Goldin R.M. The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J. Virol. 62 12 (1988) 4510-4522
46. Shah A.C., Benos D., Gillespie G.Y., and Markert J.M. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J. Neurooncol. 65 3 (2003) 203-226
47. Soliman T.M., Sandri-Goldin R.M., and Silverstein S.J. Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J. Virol. 71 12 (1997) 9188-9197
48. Stanziale S.F., Petrowsky H., Adusumilli P.S., Ben-Porat L., Gonen M., and Fong Y. Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity. Clin. Cancer Res. 10 9 (2004) 3225-3232
49. Villa P., Kaufmann S.H., and Earnshaw W.C. Caspases and caspase inhibitors. Trends Biochem. Sci. 22 10 (1997) 388-393
50. Visalli R.J., and Brandt C.R. The HSV-1 UL45 gene product is not required for growth in Vero cells. Virology 185 1 (1991) 419-423
51. Voelkel-Johnson C., Entingh A.J., Wold W.S., Gooding L.R., and Laster S.M. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J. Immunol. 154 4 (1995) 1707-1716
52. Wasilenko S.T., Meyers A.F., Vander Helm K., and Barry M. Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore. J. Virol. 75 23 (2001) 11437-11448
53. Woo M., Hakem R., Soengas M.S., Duncan G.S., Shahinian A., Kagi D., Hakem A., McCurrach M., Khoo W., Kaufman S.A., Senaldi G., Howard T., Lowe S.W., and Mak T.W. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12 6 (1998) 806-819
54. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 5756 (1980) 555-556
55. Wyllie A.H., Kerr J.F., and Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68 (1980) 251-306
56. Xu J., Keeton A.B., Wu L., Franklin J.L., Cao X., and Messina J.L. Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression. Breast Cancer Res. Treat. 91 3 (2005) 207-215
57. Yang X.H., Edgerton S., and Thor A.D. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int. J. Oncol. 26 6 (2005) 1675-1680
58. Yang X.H., Sladek T.L., Liu X., Butler B.R., Froelich C.J., and Thor A.D. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 61 1 (2001) 348-354
59. Zhang B., Zhang Y., Dagher M.C., and Shacter E. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 65 14 (2005) 6054-6062
60. Zhou G., and Roizman B. Truncated forms of glycoprotein D of herpes simplex virus 1 capable of blocking apoptosis and of low-efficiency entry into cells form a heterodimer dependent on the presence of a cysteine located in the shared transmembrane domains. J. Virol. 76 22 (2002) 11469-11475